Cargando…
Selection of a Nuclease-Resistant RNA Aptamer Targeting CD19
SIMPLE SUMMARY: Haematological malignancies show a constantly growing incidence, accounting for 6.5% of new cancer cases worldwide. Among them, B-cell neoplasms often show resistance to conventional chemotherapy that is also associated with numerous adverse effects. Therefore, in order for the treat...
Autores principales: | Esposito, Carla L., Van Roosbroeck, Katrien, Santamaria, Gianluca, Rotoli, Deborah, Sandomenico, Annamaria, Wierda, William G., Ferrajoli, Alessandra, Ruvo, Menotti, Calin, George A., de Franciscis, Vittorio, Catuogno, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533794/ https://www.ncbi.nlm.nih.gov/pubmed/34680368 http://dx.doi.org/10.3390/cancers13205220 |
Ejemplares similares
-
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
por: Catuogno, Silvia, et al.
Publicado: (2016) -
Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells
por: Esposito, Carla Lucia, et al.
Publicado: (2014) -
Identification of a novel RNA aptamer that selectively targets breast cancer exosomes
por: Esposito, Carla Lucia, et al.
Publicado: (2021) -
Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option
por: Catuogno, Silvia, et al.
Publicado: (2018) -
Coupling Aptamers to Short Interfering RNAs as Therapeutics
por: Cerchia, Laura, et al.
Publicado: (2011)